Jill D. Smith

Biography

Jill D. Smith has been a member of the Board of Directors since the Company’s inception in February 2014, and is a member of Endo’s Operations Committee and a member of Endo’s Audit Committee. Ms. Smith has been an international business leader for more than 25 years, including 16 years as a CEO of private and public companies in the technology and information services markets. Ms. Smith is currently President and CEO of Allied Minds, a life sciences and technology commercialization company, where she has served as a Director since 2016. Previously, Ms. Smith was the Chairman, CEO and President of DigitalGlobe Inc., a leading provider of satellite imagery products and services to governments and companies worldwide. She has also served on the corporate boards of Elster Group, SoundBite Communications, Inc., and Hexagon AB. Ms. Smith was a Director of Endo Health Solutions Inc. from September 2012 until February 2014. Ms. Smith’s qualifications to serve on the Board of Endo include, among others, her extensive executive- and board-level experience at publicly traded and private companies.         Jill D. Smith has been a member of the Board of Directors since the Company’s inception in February 2014, and is a member of Endo’s Operations Committee and a member of Endo’s Audit Committee. Ms. Smith has been an international business leader for more than 25 years, including 16 years as a CEO of private and public companies in the technology and information services markets. Ms. Smith is currently President and CEO of Allied Minds, a life sciences and technology commercialization company, where she has served as a Director since 2016. Previously, Ms. Smith was the Chairman, CEO and President of DigitalGlobe Inc., a leading provider of satellite imagery products and services to governments and companies worldwide. She has also served on the corporate boards of Elster Group, SoundBite Communications, Inc., and Hexagon AB. Ms. Smith was a Director of Endo Health Solutions Inc. from September 2012 until February 2014. Ms. Smith’s qualifications to serve on the Board of Endo include, among others, her extensive executive- and board-level experience at publicly traded and private companies.        

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters